You searched for "EMG"
HearAdvisor’s scientific and consumer-friendly approach to evaluating hearing aids
4 September 2023
| Andrew Sabin, Steven Ronald Taddei, Abram Bailey
|
ENTA - Audiology - Adult, ENTA - Auditory Implants
An ageing population means more hearing aid users. The authors of this article describe their techniques for independently assessing prescription and over-the-counter hearing aids in an acoustic laboratory. As the role of consumers in the hearing aid purchasing decision continues...
Rhinology, Sofia and freedom
Our president-elect and host of the ERS2023 shares her love for ERS, rhinology in general, and Bulgaria. Let her invitation to experience the “freedom to breathe” inspire us all to visit Sophia and enjoy a great congress in a fantastic...The importance of s-ABR in auditory disorders
4 May 2023
| Meliha Basoz Behmen, Elif Kuru
|
ENTA - Audiology - Adult, ENTA - Speech and Language Therapy
S-ABR is a method of recording speech-evoked-potentials, but where does it fit in the clinical and research test battery? Here, the authors examine the opportunities for s-ABR. The integrity of the neural transmission of acoustic stimuli is evaluated by auditory...
Grasping opportunities and taking chances: an accidental journey to the perfect destination
3 July 2023
| Jonathan Parsons
|
ENTA - Audiology - Adult
Here, Jonathan Parsons tells us more about his journey from clinical audiologist to setting up a social enterprise in the National Health Service. My route to Exeter and to a social enterprise has had several twists and turns and not...
FDA Approved Lenire Expands Number of US Clinics
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.Guillotines from Joseph‑Ignace Guillotin to Greenfield Sluder
3 November 2023
| Wolf Lűbbers
|
ENTA - ENT
Joseph‑Ignace Guillotin. The politician and physician Joseph-Ignace Guillotin (1738-1814) was so disgusted by brutal head and shoulder injuries sustained in ‘failed attempts’ by drunken axe-wielding executioners during the French Revolution that he and surgeon Antoine Louis (1723-1792) advocated not only...
The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis
4 July 2024
| Andreas H Müller (Prof), Stefan Kabas, Declan Costello
|
ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...
The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis
4 July 2024
| Andreas H Müller (Prof), Stefan Kabas, Declan Costello
|
ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...
App-solute relief: tackling tinnitus with your smartphone
4 July 2024
| Nyla Razaq
|
ENTA - Tinnitus
The sound experienced by individuals with tinnitus can vary to a huge extent. It can range from a mild occasional ringing to a constant, loud noise causing disruption to daily life and sleep. Reassuringly, tinnitus is rarely a sign of...
Down with the nose, down with it flat
4 July 2024
| John Riddington Young
|
ENTA - ENT
In Shakespeare’s Timon of Athens, Timon urges prostitutes to spread syphilis throughout Athens. He implores the whores, Phrynia and Timandra, to: Consumptions* sow In hollow bones of man; strike their sharp shins,And mar men’s spurring*. Crack the lawyer’s voice**, That...
Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications
12 September 2024
|
Company Profiles, Research & Development
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.
Facing changes after surgery through portraiture
4 September 2023
| Lucy Burscough
|
ENTA - ENT, ENTA - Maxillofacial Surgery, ENTA - Rhinology / Sinus
‘Facing Out: Life After Treatment for Facial Cancer’ was a two-year arts-for-health project funded by Arts Council England and The National Lottery which culminated in an exhibition at The Whitworth Art Gallery, Manchester, in February 2019. Here, artist and project...
